{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T10:03:48Z","timestamp":1756893828317},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Heart Fail Rep"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1007\/s11897-008-0036-7","type":"journal-article","created":{"date-parts":[[2009,1,7]],"date-time":"2009-01-07T15:09:37Z","timestamp":1231340977000},"page":"238-244","source":"Crossref","is-referenced-by-count":9,"title":["Management of peripartum cardiomyopathy"],"prefix":"10.1007","volume":"5","author":[{"given":"Karen","family":"Sliwa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kemi","family":"Tibazarwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"Hilfiker-Kleiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,1,8]]},"reference":[{"key":"36_CR1","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1001\/jama.283.9.1183","volume":"283","author":"G.D. Pearson","year":"2000","unstructured":"Pearson GD, Veille JC, Rahimtoola S, et al.: Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 2000, 283:1183\u20131188.","journal-title":"JAMA"},{"key":"36_CR2","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(06)69253-2","volume":"368","author":"K. Sliwa","year":"2006","unstructured":"Sliwa K, Fett J, Elkayam U: Peripartum cardiomyopathy. Lancet 2006, 368:687\u2013693.","journal-title":"Lancet"},{"key":"36_CR3","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1161\/01.CIR.0000162478.36652.7E","volume":"111","author":"U. Elkayam","year":"2005","unstructured":"Elkayam U, Akhter MW, Singh H, et al.: Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 2005, 111:2050\u20132055.","journal-title":"Circulation"},{"key":"36_CR4","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/01.AOG.0000161382.30233.ba","volume":"105","author":"J.B. Chapa","year":"2005","unstructured":"Chapa JB, Heiberger HB, Weinert L, et al.: Prognostic value of echocardiography in peripartum cardiomyopathy. Obstet Gynecol 2005, 105:1303\u20131308.","journal-title":"Obstet Gynecol"},{"key":"36_CR5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1160\/TH07-05-0373","volume":"99","author":"W.J. Kist","year":"2008","unstructured":"Kist WJ, Janssen NG, Kalk JJ, et al.: Thrombophilias and adverse pregnancy outcome\u2014a confounded problem! Thromb Haemost 2008, 99:77\u201385.","journal-title":"Thromb Haemost"},{"key":"36_CR6","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","volume":"113","author":"B.J. Maron","year":"2006","unstructured":"Maron BJ, Towbin JA, Thiene G, et al.: Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups, and Council on Epidemiology and Prevention. Circulation 2006, 113:1807\u20131816.","journal-title":"Circulation"},{"key":"36_CR7","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","volume":"29","author":"P. Elliott","year":"2008","unstructured":"Elliott P, Andersson B, Arbustini E, et al.: Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2008, 29:270\u2013276.","journal-title":"Eur Heart J"},{"key":"36_CR8","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/01.AOG.0000174580.24281.e6","volume":"106","author":"C. Deneux-Tharaux","year":"2005","unstructured":"Deneux-Tharaux C, Berg C, Bouvier-Colle MH, et al.: Underreporting of pregnancy-related mortality in the United States or Europe. Obstet Gynecol 2005, 106:684\u2013692. [Published erratum appears in Obstet Gynecol 2006, 107:209.]","journal-title":"Obstet Gynecol"},{"key":"36_CR9","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.amjcard.2007.02.092","volume":"100","author":"S.S. Brar","year":"2007","unstructured":"Brar SS, Khan SS, Sandhu GK, et al.: Incidence, mortality, and racial differences in peripartum cardiomyopathy. Am J Cardiol 2007, 100:302\u2013304.","journal-title":"Am J Cardiol"},{"key":"36_CR10","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1161\/01.CIR.0000101920.72665.58","volume":"108","author":"Y. Hayakawa","year":"2003","unstructured":"Hayakawa Y, Chandra M, Miao W, et al.: Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy of Galpha(q) transgenic mice. Circulation 2003, 108:3036\u20133041.","journal-title":"Circulation"},{"key":"36_CR11","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.cell.2006.12.036","volume":"128","author":"D. Hilfiker-Kleiner","year":"2007","unstructured":"Hilfiker-Kleiner D, Kaminski K, Podewski E, et al.: A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 2007, 128:589\u2013600.","journal-title":"Cell"},{"key":"36_CR12","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.ejheart.2008.07.005","volume":"10","author":"O. Forster","year":"2008","unstructured":"Forster O, Hilfiker-Kleiner D, Ansari A, et al.: Reversal of IFN-gamma, oxLDL and prolactin serum levels correlate with clinical improvement in patients with peripartum cardiomyopathy. Eur J Heart Fail 2008, 10:861\u2013868.","journal-title":"Eur J Heart Fail"},{"key":"36_CR13","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1161\/CIRCULATIONAHA.107.727073","volume":"117","author":"A. Diwan","year":"2008","unstructured":"Diwan A, Wansapura J, Syed FM, et al.: Nix-mediated apoptosis links myocardial fibrosis, cardiac remodeling, and hypertrophy decompensation. Circulation 2008, 117:396\u2013404.","journal-title":"Circulation"},{"key":"36_CR14","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0167-5273(02)00359-5","volume":"86","author":"J.D. Fett","year":"2002","unstructured":"Fett JD, Ansari AA, Sundstrom JB, Combs GF: Peripartum cardiomyopathy: a selenium disconnection and an autoimmune connection. Int J Cardiol 2002, 86:311\u2013316.","journal-title":"Int J Cardiol"},{"key":"36_CR15","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/0002-8703(95)90089-6","volume":"130","author":"M.B. Lampert","year":"1995","unstructured":"Lampert MB, Lang RM: Peripartum cardiomyopathy. Am Heart J 1995, 130:860\u2013870.","journal-title":"Am Heart J"},{"key":"36_CR16","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0735-1097(99)00624-5","volume":"35","author":"K. Sliwa","year":"2000","unstructured":"Sliwa K, Skudicky D, Bergemann A, et al.: Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas\/APO-1. J Am Coll Cardiol 2000, 35:701\u2013705.","journal-title":"J Am Coll Cardiol"},{"key":"36_CR17","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1388-9842(02)00008-9","volume":"4","author":"K. Sliwa","year":"2002","unstructured":"Sliwa K, Skudicky D, Candy G, et al.: The addition of pentoxifylline to conventional therapy improves outcome in patients with peripartum cardiomyopathy. Eur J Heart Fail 2002, 4:305\u2013309.","journal-title":"Eur J Heart Fail"},{"key":"36_CR18","first-page":"587","volume":"2","author":"O. Forster","year":"2006","unstructured":"Forster O, Ansari AA, Sliwa K: Current issues in diagnosis and management of peripartum cardiomyopathy. Womens Health 2006, 2:587\u2013596.","journal-title":"Womens Health"},{"key":"36_CR19","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/eurheartj\/ehi044","volume":"26","author":"M.S. Nieminen","year":"2005","unstructured":"Nieminen MS, Bohm M, Cowie MR, et al.: Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005, 26:384\u2013416.","journal-title":"Eur Heart J"},{"key":"36_CR20","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/eurheartj\/ehi481","volume":"27","author":"K. Sliwa","year":"2006","unstructured":"Sliwa K, Forster O, Libhaber E, et al.: Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J 2006, 27:441\u2013446.","journal-title":"Eur Heart J"},{"key":"36_CR21","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ajog.2005.01.022","volume":"193","author":"B.D. Bultmann","year":"2005","unstructured":"Bultmann BD, Klingel K, Nabauer M, et al.: High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. Am J Obstet Gynecol 2005, 193:363\u2013365.","journal-title":"Am J Obstet Gynecol"},{"key":"36_CR22","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0248-8663(05)80150-X","volume":"14","author":"A. Cenac","year":"1993","unstructured":"Cenac A, Djibo A, Djangnikpo L: Peripartum dilated cardiomyopathy. A model of multifactor disease? [in French]. Rev Med Interne 1993, 14:1033.","journal-title":"Rev Med Interne"},{"key":"36_CR23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijgo.2007.01.012","volume":"97","author":"J.D. Fett","year":"2007","unstructured":"Fett JD: Viral infection as a possible trigger for the development of peripartum cardiomyopathy. Int J Gynaecol Obstet 2007, 97:149\u2013150.","journal-title":"Int J Gynaecol Obstet"},{"key":"36_CR24","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/0002-9149(94)90906-7","volume":"74","author":"M.N. Rizeq","year":"1994","unstructured":"Rizeq MN, Rickenbacher PR, Fowler MB, Billingham ME: Incidence of myocarditis in peripartum cardiomyopathy. Am J Cardiol 1994, 74:474\u2013477.","journal-title":"Am J Cardiol"},{"key":"36_CR25","first-page":"287","volume":"3","author":"R.G. Harrison","year":"1979","unstructured":"Harrison RG: Suppression of lactation. Semin Perinatol 1979, 3:287\u2013297.","journal-title":"Semin Perinatol"},{"key":"36_CR26","first-page":"1890","volume":"26","author":"H. Nagafuchi","year":"1999","unstructured":"Nagafuchi H, Suzuki N, Kaneko A, et al.: Prolactin locally produced by synovium infiltrating T lymphocytes induces excessive synovial cell functions in patients with rheumatoid arthritis. J Rheumatol 1999, 26:1890\u20131900.","journal-title":"J Rheumatol"},{"key":"36_CR27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0167-5273(96)02906-3","volume":"60","author":"S.S. Kothari","year":"1997","unstructured":"Kothari SS: Aetiopathogenesis of peripartum cardiomyopathy: prolactin-selenium interaction? Int J Cardiol 1997, 60:111\u2013114.","journal-title":"Int J Cardiol"},{"key":"36_CR28","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(06)68506-1","volume":"367","author":"J.V. Peter","year":"2006","unstructured":"Peter JV, Moran JL, Phillips-Hughes J, et al.: Effect of noninvasive positive pressure ventilation (NIPPV) on mortality in patients with acute cardiogenic pulmonary oedema: a meta-analysis. Lancet 2006, 367:1155\u20131163.","journal-title":"Lancet"},{"key":"36_CR29","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/eurheartj\/ehi044","volume":"26","author":"M.S. Nieminen","year":"2005","unstructured":"Nieminen MS, B\u00f6m M, Cowie MR, et al.: Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005, 26:384\u2013416.","journal-title":"Eur Heart J"},{"key":"36_CR30","first-page":"801","volume":"16","author":"M.R. Johnson","year":"1997","unstructured":"Johnson MR, Naftel DC, Hobbs RE, et al.: The incremental risk of female sex in heart transplantation: a multiinstitutional study of peripartum cardiomyopathy and pregnancy. Cardiac Transplant Research Database Group. J Heart Lung Transplant 1997, 16:801\u2013812.","journal-title":"J Heart Lung Transplant"},{"key":"36_CR31","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00007611-198904000-00030","volume":"82","author":"P.G. Hovsepian","year":"1989","unstructured":"Hovsepian PG, Ganzel B, Sohi GS, et al.: Peripartum cardiomyopathy treated with a left ventricular assist device as a bridge to cardiac transplantation. South Med J 1989, 82:527\u2013528.","journal-title":"South Med J"},{"key":"36_CR32","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1016\/j.jacc.2007.10.006","volume":"50","author":"D. Hilfiker-Kleiner","year":"2007","unstructured":"Hilfiker-Kleiner D, Meyer GP, Schieffer E, et al.: Recovery from postpartum cardiomyopathy in 2 patients by blocking prolactin release with bromocriptine. J Am Coll Cardiol 2007, 50:2354\u20132355.","journal-title":"J Am Coll Cardiol"},{"key":"36_CR33","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1056\/NEJMoa021266","volume":"347","author":"S.S. Rathore","year":"2002","unstructured":"Rathore SS, Wang Y, Krumholz HM: Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med 2002, 347:1403\u20131411.","journal-title":"N Engl J Med"},{"key":"36_CR34","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jacc.2005.02.091","volume":"46","author":"K.F. Adams Jr","year":"2005","unstructured":"Adams KF Jr, Patterson JH, Gattis WA, et al.: Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysis. J Am Coll Cardiol 2005, 46:497\u2013504.","journal-title":"J Am Coll Cardiol"},{"key":"36_CR35","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4065\/80.12.1602","volume":"80","author":"J.D. Fett","year":"2005","unstructured":"Fett JD, Christie LG, Carraway RD, Murphy JG: Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clin Proc 2005, 80:1602\u20131606.","journal-title":"Mayo Clin Proc"},{"key":"36_CR36","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1056\/NEJM200004133421502","volume":"342","author":"G.M. Felker","year":"2000","unstructured":"Felker GM, Thompson RE, Hare JM, et al.: Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000, 342:1077\u20131084.","journal-title":"N Engl J Med"},{"key":"36_CR37","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/17402520500304352","volume":"12","author":"J.E. Ellis","year":"2005","unstructured":"Ellis JE, Ansari AA, Fett JD, et al.: Inhibition of progenitor dendritic cell maturation by plasma from patients with peripartum cardiomyopathy: role in pregnancy-associated heart disease. Clin Dev Immunol 2005, 12:265\u2013273.","journal-title":"Clin Dev Immunol"},{"key":"36_CR38","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.amjcard.2004.02.053","volume":"93","author":"K. Sliwa","year":"2004","unstructured":"Sliwa K, Forster O, Zhanje F, et al.: Outcome of subsequent pregnancy in patients with documented peripartum cardiomyopathy. Am J Cardiol 2004, 93:1441\u20131443.","journal-title":"Am J Cardiol"},{"key":"36_CR39","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJM200105243442101","volume":"344","author":"U. Elkayam","year":"2001","unstructured":"Elkayam U, Tummala PP, Rao K, et al.: Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med 2001, 344:1567\u20131571. [Published erratum appears in N Engl J Med 2001, 345:552.]","journal-title":"N Engl J Med"}],"container-title":["Current Heart Failure Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-008-0036-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11897-008-0036-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-008-0036-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:09:51Z","timestamp":1559434191000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11897-008-0036-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["36"],"URL":"https:\/\/doi.org\/10.1007\/s11897-008-0036-7","relation":{},"ISSN":["1546-9530","1546-9549"],"issn-type":[{"value":"1546-9530","type":"print"},{"value":"1546-9549","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}